SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-012464
Filing Date
2017-01-18
Accepted
2017-01-18 17:19:55
Documents
3
Group Members
KIKU MERGER CO., INC.TPA HOLDING I, INC.TPA HOLDING II, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D d329612dsc13d.htm SC 13D 127361
2 EX-99.3 d329612dex993.htm EX-99.3 40492
3 99.EX-4 d329612dex994.htm EX-99.4 6197
  Complete submission text file 0001193125-17-012464.txt   175556
Mailing Address 125 BINNEY STREET CAMBRIDGE MA 02142
Business Address 125 BINNEY STREET CAMBRIDGE MA 02142 6174940400
ARIAD PHARMACEUTICALS INC (Subject) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48751 | Film No.: 17534170
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D